Metin Akay, Ph.D.
Founding Chair, John S. Dunn Endowed Chair Professor
Biomedical Engineering
University of Houston

Dr. Akay is currently the founding chair of the new Biomedical Engineering Department and the John S. Dunn professor of biomedical engineering at the University of Houston. He received his B.S. and M.S. in Electrical Engineering from the Bogazici University, Istanbul, Turkey in 1981 and 1984, respectively and a Ph.D. degree from Rutgers University in 1990. He serves on the editorial or advisory board of several international journals including the IEEE T-BME, IEEE T-NSRE, IEEE T-ITIB, Proc of IEEE, Journal of Neural Engineering, NIH Neural Engineering and Bioengineering partnership study sections and several NSF review panels. Dr. Akay’s Neural Engineering and Informatics Lab is interested in developing an intelligent wearable system for monitoring motor tasks in Parkinson and Post-Stroke Disease Subjects and investigating the developmental abnormalities of medullary respiratory neurons during early maturation and the sudden infant death syndromes.

Donald E. Mager, Pharm.D., Ph.D.
Associate Professor
Pharmaceutical Sciences
University of Buffalo, SUNY

Dr. Mager is an Associate Professor of Pharmaceutical Sciences at the University at Buffalo, State University of New York. He was also a Visiting Professor at the University Paris Descartes in January from 2007 – 2013. He currently serves on the Clinical Pharmacology Advisory Committee to the FDA, on the editorial boards of several journals, and as an Associate or Consulting Editor at CPT: Pharmacometrics & Systems Pharmacology, Journal of Pharmacology & Experimental Therapeutics, and Pharmacology, Research & Perspectives. He is a Fellow of the American College of Clinical Pharmacology and is President of the International Society of Pharmacometrics. His research focuses on identifying molecular and physiological factors that control the pharmacological properties of diverse drugs, with a focus on anti-cancer and immunomodulatory agents.

Thomas Penzel, Ph.D.
Professor
Sleep Research Center
Charité Universitätsmedizin Berlin

Dr. Penzel is the director of research of the Interdisciplinary Sleep Medicine Centre at the Charité University Hospital, Berlin, Germany, since 2006. He studied physics, human biology, physiology and medical informatics at the University Marburg, Germany. In 2001, he received the Bial Award in Clinical Medicine in Portugal, in 2008 the Bill Gruen Award for Innovations in Sleep Research by the American Sleep Research Society, and in 2012 the Somnus Award by the Sleep magazine in Germany. He is the chair of the Sleep Medicine Committee of the ESRS. He is the secretary of the German Sleep Society, the treasurer of the World Association of Sleep Medicine, the editor-in-chief of the German journal Somnologie. He published more than 200 papers on sleep research and sleep medicine with a focus on methodology, sleep disordered breathing and the cardiovascular system during sleep.

Robert J. Sclabassi, M.D., Ph.D.
CEO
Computational Diagnostics, Inc.

Dr. Sclabassi earned his B.S. in Engineering from Loyola University of Los Angeles and an MSEE and a Ph.D. in Electrical Engineering, all from the University of Southern California. He also has an MD from the University of Pittsburgh and has completed post-graduate work in the Department of Neurology, University of California at Los Angeles. He has held faculty positions at UCLA, CMU and the University of Pittsburgh. He retired from the University of Pittsburgh in 2008 as a Professor of Neurosurgery, Psychiatry, Neuroscience, Electrical Engineering and Biomedical Engineering. He has written over 500 papers and book chapters and has sixteen patents. He has also worked as an engineering manager, at TRW, Redondo Beach CA, on new product development in the Advanced Systems Laboratory. He has been the Vice-President of Engineering at LimTech, Inc., a startup company spun out of TRW. He serves on the boards of Decision Resources, Inc., Neuro-Kinetics, Inc., CerebroScope, LLC and Pittsburgh Opera. He is also on the Board of Trustees of Loyola Marymount University. Dr. Sclabassi is currently the CEO and Board Chair of Computational Diagnostics, Inc., a company he founded in 1989.